Divalproex sodium NDC 62332-821

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-821Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0821Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-821-10	62332082110	100 BLISTER PACK in 1 CARTON (62332-821-10) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACKMarketed from Dec 23, 2024
62332-821-31	62332082131	100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-31)Marketed from Dec 23, 2024
62332-821-71	62332082171	500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-71)Marketed from Mar 21, 2025
62332-821-91	62332082191	1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-91)Marketed from Dec 23, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Divalproex sodium
Generic name (nonproprietary): divalproex sodium
Active ingredients: Divalproex sodium — 125 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218793
Marketing start: Dec 23, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 62332-821_650146da-3899-4750-8c6e-954ddd19f23aSPL ID 650146da-3899-4750-8c6e-954ddd19f23aSPL set ID fea19b14-d8ed-4954-bc54-b9240f78b3c3RxCUI 1099596UNII 644VL95AO6UPC 0362332821716, 0362332821310
Pharmacologic class: Anti-epileptic Agent; Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332082110 followed by a unit qualifier and the quantity

Package 62332-0821-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 8, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Divalproex sodium delayed-release capsules are an anti-epileptic drug indicated for: • Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1 ) 1.1 Epilepsy Divalproex sodium delayed-release capsules are indicated as monotherapy and adjunctive therapy in the treatment of adult patients and pediatric patients down to the age of 10 years with complex partial seizures that occur either in isolation or in association with other types of seizures. Divalproex sodium delayed-release capsules are also indicated for use as sole and adjunctive therapy in the tre…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218793

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218793
Product	Strength	Form · route	Labeler	Product NDC
Divalproex sodium	Divalproex sodium 125 mg/1	Capsule, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-821